Summary
89.08 -0.89(-0.99%)05/16/2024
Alcon Inc. (ALC)
Alcon Inc. (ALC)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| 0.70 | 4.37 | -3.41 | 5.35 | 9.91 | 8.09 | 39.42 | 40.11 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 80.97 | |
| Open | 79.90 | |
| High | 81.18 | |
| Low | 79.90 | |
| Volume | 941,924 | |
| Change | 0.56 | |
| Change % | 0.70 | |
| Avg Volume (20 Days) | 770,877 | |
| Volume/Avg Volume (20 Days) Ratio | 1.22 | |
| 52 Week Range | 69.44 - 88.23 | |
| Price vs 52 Week High | -8.23% | |
| Price vs 52 Week Low | 16.60% | |
| Range | 1.34 | |
| Gap Up/Down | -0.61 | |
Fundamentals | ||
| Market Capitalization (Mln) | 44,195 | |
| EBIDTA | 1,924,999,936 | |
| PE Ratio | 123.0643 | |
| PEG Ratio | 0.0000 | |
| WallStreet Target Price | 85.83 | |
| Book Value | 38.9570 | |
| Earnings Per Share | 0.6690 | |
| EPS Estimate Current Quarter | 0.4900 | |
| EPS Estimate Next Quarter | 0.5200 | |
| EPS Estimate Current Year | 2.0700 | |
| EPS Estimate Next Year | 2.4100 | |
| Diluted EPS (TTM) | 0.6690 | |
| Revenues | ||
| Profit Marging | 0.0411 | |
| Operating Marging (TTM) | 0.0919 | |
| Return on asset (TTM) | 0.0168 | |
| Return on equity (TTM) | 0.0176 | |
| Revenue TTM | 8,081,999,872 | |
| Revenue per share TTM | 16.5020 | |
| Quarterly Revenue Growth (YOY) | 0.1440 | |
| Quarterly Earnings Growth (YOY) | 0.0000 | |
| Gross Profit (TTM) | 3,056,000,000 | |
| Dividends | ||
| Dividend Share | 0.1130 | |
| Dividend Yield | 0.0014 | |
| Valuations | ||
| Trailing PE | 123.0643 | |
| Forward PE | 35.0877 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 2.1603 | |
| Revenue Enterprise Value | 5.4466 | |
| EBITDA Enterprise Value | 23.3400 | |
| Shares | ||
| Shares Outstanding | 490,100,000 | |
| Shares Float | 489,717,722 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.00 | |
| Insider (%) | 0.06 | |
| Institutions (%) | 56.19 | |
05/15 10:45 EST - zacks.com
3 Solid Buys From MedTech Following 2024 Guidance Raise
Guidance hikes by BSX, ALGN and ALC for 2024 make them attractive investment bets.
3 Solid Buys From MedTech Following 2024 Guidance Raise
Guidance hikes by BSX, ALGN and ALC for 2024 make them attractive investment bets.
05/14 13:56 EST - zacks.com
Alcon (ALC) Q1 Earnings Surpass Estimates, Margins Expand
Alcon's (ALC) Q1 results reflect substantial growth in its franchises on the back of healthy markets.
Alcon (ALC) Q1 Earnings Surpass Estimates, Margins Expand
Alcon's (ALC) Q1 results reflect substantial growth in its franchises on the back of healthy markets.
05/14 10:48 EST - seekingalpha.com
Alcon Inc. (ALC) Q1 2024 Earnings Call Transcript
Alcon Inc. (NYSE:ALC ) Q1 2024 Earnings Conference Call May 14, 2024 8:00 AM ET Company Participants Dan Cravens - Vice President, Investor Relations David Endicott - Chief Executive Officer Tim Stonesifer - Chief Financial Officer Conference Call Participants Graham Doyle - UBS Veronica Dubajova - Citi Ryan Zimmerman - BTIG Richard Felton - Goldman Sachs Larry Biegelsen - Wells Fargo Jack Reynolds-Clark - RBC Capital Markets David Saxon - Needham & Co Michael Sarcone - Jefferies Brett Fishbin - KeyBanc Capital Markets Anthony Petrone - Mizuho Group Issie Kirby - Redburn Atlantic Tom Stephan - Stifel Operator Greetings, and welcome to the Alcon's First Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode.
Alcon Inc. (ALC) Q1 2024 Earnings Call Transcript
Alcon Inc. (NYSE:ALC ) Q1 2024 Earnings Conference Call May 14, 2024 8:00 AM ET Company Participants Dan Cravens - Vice President, Investor Relations David Endicott - Chief Executive Officer Tim Stonesifer - Chief Financial Officer Conference Call Participants Graham Doyle - UBS Veronica Dubajova - Citi Ryan Zimmerman - BTIG Richard Felton - Goldman Sachs Larry Biegelsen - Wells Fargo Jack Reynolds-Clark - RBC Capital Markets David Saxon - Needham & Co Michael Sarcone - Jefferies Brett Fishbin - KeyBanc Capital Markets Anthony Petrone - Mizuho Group Issie Kirby - Redburn Atlantic Tom Stephan - Stifel Operator Greetings, and welcome to the Alcon's First Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode.
05/13 20:31 EST - zacks.com
Compared to Estimates, Alcon (ALC) Q1 Earnings: A Look at Key Metrics
Although the revenue and EPS for Alcon (ALC) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Compared to Estimates, Alcon (ALC) Q1 Earnings: A Look at Key Metrics
Although the revenue and EPS for Alcon (ALC) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
05/13 20:21 EST - zacks.com
2 Intriguing Medical Stocks to Buy for Steady Growth as Earnings Approach
Among the medical sector, Alcon (ALC) and Prestige Consumer Healthcare (PBH) are two intriguing stocks to buy for growth as their quarterly results approach on Tuesday, May 14.
2 Intriguing Medical Stocks to Buy for Steady Growth as Earnings Approach
Among the medical sector, Alcon (ALC) and Prestige Consumer Healthcare (PBH) are two intriguing stocks to buy for growth as their quarterly results approach on Tuesday, May 14.
05/13 16:30 EST - businesswire.com
Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health
GENEVA--(BUSINESS WIRE)--Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health.
Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health
GENEVA--(BUSINESS WIRE)--Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health.
05/10 09:56 EST - zacks.com
Why Alcon (ALC) Might Surprise This Earnings Season
Alcon (ALC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Why Alcon (ALC) Might Surprise This Earnings Season
Alcon (ALC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
05/07 12:41 EST - zacks.com
ALC vs. EW: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Instruments sector have probably already heard of Alcon (ALC) and Edwards Lifesciences (EW). But which of these two stocks presents investors with the better value opportunity right now?
ALC vs. EW: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Instruments sector have probably already heard of Alcon (ALC) and Edwards Lifesciences (EW). But which of these two stocks presents investors with the better value opportunity right now?
04/16 06:25 EST - marketbeat.com
Star Surgical Shines as U.S. Outlook Improves for 2024
STAAR Surgical Co. NASDAQ: STAA develops and manufactures intraocular lenses (IOL) used to replace a person's natural lenses during cataract surgery. Its portfolio includes the EVO line of Implantable Collamer Lenses (ICL) used for the treatment of nearsightedness (myopia), refractive error (astigmatism) and farsightedness (presbyopia).
Star Surgical Shines as U.S. Outlook Improves for 2024
STAAR Surgical Co. NASDAQ: STAA develops and manufactures intraocular lenses (IOL) used to replace a person's natural lenses during cataract surgery. Its portfolio includes the EVO line of Implantable Collamer Lenses (ICL) used for the treatment of nearsightedness (myopia), refractive error (astigmatism) and farsightedness (presbyopia).
04/07 17:59 EST - businesswire.com
Alcon Publishes Agenda for 2024 Annual General Meeting
GENEVA--(BUSINESS WIRE)--Alcon Publishes Agenda for 2024 Annual General Meeting.
Alcon Publishes Agenda for 2024 Annual General Meeting
GENEVA--(BUSINESS WIRE)--Alcon Publishes Agenda for 2024 Annual General Meeting.
04/03 10:56 EST - zacks.com
Here's Why Investors Should Buy Alcon (ALC) Stock Right Now
Strength in the Surgical and Vision Care businesses bodes well for Alcon (ALC).
Here's Why Investors Should Buy Alcon (ALC) Stock Right Now
Strength in the Surgical and Vision Care businesses bodes well for Alcon (ALC).
03/13 09:35 EST - zacks.com
Alcon's (ALC) New Launch Strengthens IOL Innovation Leadership
Alcon's (ALC) Clareon platform is available in India in two PCIOL technologies, PanOptix and Vivity.
Alcon's (ALC) New Launch Strengthens IOL Innovation Leadership
Alcon's (ALC) Clareon platform is available in India in two PCIOL technologies, PanOptix and Vivity.
03/12 04:43 EST - headlinesoftoday.com
Alcon Strengthens Leadership in IOL Innovation with the launch of the Clareon Presbyopia Correcting IOLs in India
Clareon PCIOLs deliver excellent vision, exceptional clarity and predictable refractive outcomes in a glistening-free§ IOL material12-14 Clareon IOLs offer long-lasting clarity backed by extensive real-world experience with excellent outcomes, which is demonstrated in 30 peer-reviewed studies15-17 BENGALURU, India–(BUSINESS WIRE)–Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced …
Alcon Strengthens Leadership in IOL Innovation with the launch of the Clareon Presbyopia Correcting IOLs in India
Clareon PCIOLs deliver excellent vision, exceptional clarity and predictable refractive outcomes in a glistening-free§ IOL material12-14 Clareon IOLs offer long-lasting clarity backed by extensive real-world experience with excellent outcomes, which is demonstrated in 30 peer-reviewed studies15-17 BENGALURU, India–(BUSINESS WIRE)–Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced …
03/08 08:36 EST - zacks.com
Alcon's (ALC) Vivity EDOF IOL Achieves One Million Milestone
Alcon's (ALC) Vivity features the first-of-its-kind, patented wavefront-shaping technology, which simplifies presbyopia correction for surgeons and patients.
Alcon's (ALC) Vivity EDOF IOL Achieves One Million Milestone
Alcon's (ALC) Vivity features the first-of-its-kind, patented wavefront-shaping technology, which simplifies presbyopia correction for surgeons and patients.
03/06 09:55 EST - businesswire.com
Vivity, the World's Leading EDOF IOL, Reaches One Million Milestone
TORONTO--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today proudly announces AcrySof® IQ Vivity® and Clareon® Vivity extended depth of focus (EDOF) intraocular lens (IOL) has surpassed more than one million implants worldwide. Vivity is the most implanted EDOF IOL globally.1* Alcon is the global leader in IOLs—every four seconds an eye is implanted with an Alcon IOL—and continues to innovate in this space to address patients.
Vivity, the World's Leading EDOF IOL, Reaches One Million Milestone
TORONTO--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today proudly announces AcrySof® IQ Vivity® and Clareon® Vivity extended depth of focus (EDOF) intraocular lens (IOL) has surpassed more than one million implants worldwide. Vivity is the most implanted EDOF IOL globally.1* Alcon is the global leader in IOLs—every four seconds an eye is implanted with an Alcon IOL—and continues to innovate in this space to address patients.
02/28 21:45 EST - seekingalpha.com
Alcon, Inc. (ALC) Q4 2023 Earnings Call Transcript
Alcon, Inc. (ALC) Q4 2023 Earnings Call Transcript
Alcon, Inc. (ALC) Q4 2023 Earnings Call Transcript
Alcon, Inc. (ALC) Q4 2023 Earnings Call Transcript
02/28 06:56 EST - zacks.com
Alcon (ALC) Q4 Earnings Beat Estimates, Margins Expand
Alcon (ALC) delivers impressive performance across its franchises in the fourth quarter of 2023.
Alcon (ALC) Q4 Earnings Beat Estimates, Margins Expand
Alcon (ALC) delivers impressive performance across its franchises in the fourth quarter of 2023.
02/27 20:01 EST - zacks.com
Alcon (ALC) Reports Q4 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Alcon (ALC) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Alcon (ALC) Reports Q4 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Alcon (ALC) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.